• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 309-323 of 901 results

1057 Exhibit: WO 2011073328

Document IPR2024-00009, No. 1057 Exhibit - WO 2011073328 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1093 Exhibit: Declaration of Dr John P Fruehauf

Document IPR2024-00009, No. 1093 Exhibit - Declaration of Dr John P Fruehauf (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1003 Exhibit: Declaration of John Bantle, MD

Document IPR2024-00009, No. 1003 Exhibit - Declaration of John Bantle, MD (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1058 Exhibit: Blonde, Comparison of Liraglutidesuppl 2 DIABETES, OBES, METAB...

Document IPR2024-00009, No. 1058 Exhibit - Blonde, Comparison of Liraglutidesuppl 2 DIABETES, OBES, METAB 2012 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1076 Exhibit: ClinicalTrialsgov Background, CLINICALTRIALSGOV

Document IPR2024-00009, No. 1076 Exhibit - ClinicalTrialsgov Background, CLINICALTRIALSGOV (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1067 Exhibit: US Patent No 8,536,122

Document IPR2024-00009, No. 1067 Exhibit - US Patent No 8,536,122 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1086 Exhibit: “Last Update Posted” definition from ClinicalTrialsgov

Document IPR2024-00009, No. 1086 Exhibit - “Last Update Posted” definition from ClinicalTrialsgov (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1068 Exhibit: US Patent No 8,129,343

Document IPR2024-00009, No. 1068 Exhibit - US Patent No 8,129,343 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1035 Exhibit: Lund, Emerging GLP 1 Receptor, 6 EXPERT OP ON EMERGING DRU...

Document IPR2024-00009, No. 1035 Exhibit - Lund, Emerging GLP 1 Receptor, 6 EXPERT OP ON EMERGING DRUGS 607 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1063 Exhibit: Kirillova, Results and Outcome,76 PLOS ONE 1 2012

Document IPR2024-00009, No. 1063 Exhibit - Kirillova, Results and Outcome,76 PLOS ONE 1 2012 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1001 Exhibit: US Patent No 10,335,462

Document IPR2024-00009, No. 1001 Exhibit - US Patent No 10,335,462 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1053 Exhibit: Møller, Mechanism Based, 38 J PHARMACOKINETICS 713 2011

Document IPR2024-00009, No. 1053 Exhibit - Møller, Mechanism Based, 38 J PHARMACOKINETICS 713 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1022 Exhibit: Drab, Incretin Based Therapies for Type 2 Diabetes PHARMA 609 20...

Document IPR2024-00009, No. 1022 Exhibit - Drab, Incretin Based Therapies for Type 2 Diabetes PHARMA 609 2010 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1002 Exhibit: Prosecution history excerpts for US Patent No 10,335,462

Document IPR2024-00009, No. 1002 Exhibit - Prosecution history excerpts for US Patent No 10,335,462 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

2008 Exhibit: EX2008 Claim Construction Order, In re Ozempic Semaglutide Paten...

Document IPR2024-00009, No. 2008 Exhibit - EX2008 Claim Construction Order, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC, Dkt 148 D Del July 25, 2023 (P.T.A.B. Jan. 26, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 21 22 23 24 25 ... >>